HSA Approval

APO-IBUPROFEN-FC TABLET 200 mg

Approval Number

SIN06016P

Drug Name

Product Name

APO-IBUPROFEN-FC TABLET 200 mg

Approval Date

June 3, 1991

Registrant

PHARMAFORTE SINGAPORE PTE LTD

Licence Holder

PHARMAFORTE SINGAPORE PTE LTD

Regulatory Information

Registrant

PHARMAFORTE SINGAPORE PTE LTD

Licence Holder

PHARMAFORTE SINGAPORE PTE LTD

Drug Type

Therapeutic

Forensic Classification

Prescription Only

Formulation Information

Dosage Form

TABLET, FILM COATED

Route of Administration

ORAL

Medical Information

ATC Code

M01AE01

ATC Item Name

ibuprofen

Manufacturer Information

Pharmaceutical Manufacturer

PHARMAFORTE SINGAPORE PTE LTD

Manufacturers

APOTEX INC

Active Ingredients

Ingredient Name

IBUPROFEN

Strength

200 mg

Drug MonographIbuprofen

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

APO-IBUPROFEN-FC TABLET 200 mg - HSA Approval | MedPath

AI-Powered Research

Premium Access

APO-IBUPROFEN-FC TABLET 200 mg

Regulatory Information

Formulation Information

Medical Information

Manufacturer Information

Active Ingredients

MedPath

Product

Company

Legal